Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Filippi

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Biomedicines|May 16, 2023
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian StudyMaria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, et al.
JAMA Pediatrics|August 25, 2025
Outcomes of Preterm Infants Born at 22 to 23 Weeks' Gestation in 11 International Neonatal NetworksTetsuya Isayama, Mikael Norman, Satoshi Kusuda, et al.
British Journal of Pharmacology|March 16, 2019
β<sub>3</sub> -Adrenoceptor as a potential immuno-suppressor agent in melanomaMaura Calvani, Gennaro Bruno, Massimo Dal Monte, et al.
BMC Pediatrics|September 7, 2012
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)Luca Filippi, Patrizio Fiorini, Marta Daniotti, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 10, 2017
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility studyLuca Filippi, Patrizio Fiorini, Serena Catarzi, et al.
Pediatric Research|November 5, 2016
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trialLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
BMC Pediatrics|November 20, 2010
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491Luca Filippi, Giacomo Cavallaro, Patrizio Fiorini, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with <sup>223</sup>RaCl<sub>2</sub>: Ten Years of Clinical ExperienceMaria Silvia De Feo, Luca Filippi, Matteo Bauckneht, et al.
BMC Pediatrics|July 16, 2017
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trialLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Pediatrics|May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB StudyLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Biomedicines|May 16, 2023
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian StudyMaria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, et al.
JAMA Pediatrics|August 25, 2025
Outcomes of Preterm Infants Born at 22 to 23 Weeks' Gestation in 11 International Neonatal NetworksTetsuya Isayama, Mikael Norman, Satoshi Kusuda, et al.
British Journal of Pharmacology|March 16, 2019
β<sub>3</sub> -Adrenoceptor as a potential immuno-suppressor agent in melanomaMaura Calvani, Gennaro Bruno, Massimo Dal Monte, et al.
BMC Pediatrics|September 7, 2012
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)Luca Filippi, Patrizio Fiorini, Marta Daniotti, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 10, 2017
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility studyLuca Filippi, Patrizio Fiorini, Serena Catarzi, et al.
Pediatric Research|November 5, 2016
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trialLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
BMC Pediatrics|November 20, 2010
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491Luca Filippi, Giacomo Cavallaro, Patrizio Fiorini, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with <sup>223</sup>RaCl<sub>2</sub>: Ten Years of Clinical ExperienceMaria Silvia De Feo, Luca Filippi, Matteo Bauckneht, et al.
BMC Pediatrics|July 16, 2017
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trialLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Pediatrics|May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB StudyLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Pageof 29